Neha Mehta-Shah: Absolutely honored and so grateful to receive this SIP grant to study an oral EZH2 inhibitor in CTCL.

Neha Mehta-Shah, an Associate Professor at Washington University in St. Louis, recently tweeted:

“Absolutely honored and so grateful to receive this SIP grant to study an oral EZH2 inhibitor in CTCL. Well-tolerated, oral effective therapies are of tremendous need in this population. Working with Payton Laboratory, George P. Souroullas, on correlatives and study quality of life Amy Musiek”

Source: Neha Mehta-Shah/Twitter